Did Paxil’s Labeling Sufficiently Warn Patients?
As long ago as 2005, the Food and Drug Administration (FDA) has been encouraging the manufacturer of Paxil (paroxetine) to take the appropriate steps to warn patients of the peril they may face as a result of their Paxil prescription. As a result, the FDA now requires that Paxil manufacturers include labels on the side of this dangerous drug’s packaging that disclose the potentially severe risks that Paxil imposes.
Chief among these risks is the threat to women who are in their first trimester that ingesting Paxil (paroxetine) will expose the fetus to a hazardous percentage of the pregnant patient’s dosage. The child developing in the womb is particularly vulnerable to dangerous drugs during the first 12 weeks of pregnancy. Tragically, Paxil’s effects can include serious birth defect, such as heart and pulmonary conditions.
The attorneys at Fears Nachawati are committed to defending the legal rights and medical interests of families like yours. If you or a loved one has been hurt by Paxil and the drug manufacturers who failed to appropriately warn their consumers, you should speak with our experts today. For your free consultation, call 1.866.545.8364 or email email@example.com. We’re ready to fight for you!